期刊文献+

帕金森病的蛋白质组学研究进展 被引量:3

下载PDF
导出
出处 《临床神经外科杂志》 CAS 2007年第2期90-93,共4页 Journal of Clinical Neurosurgery
  • 相关文献

参考文献27

  • 1[1]Zhang J.,Goodlett D.R..Proteomic approach to studying Parkinson's disease[ J].Molecular Neurobiology,2004,29:271.
  • 2[2]Abbott A.,Munich.Brain protein project enlists mice in "dry run"[J].Nature,2003,425:110.
  • 3[3]Kim S.I.,Voshol H.,Oostrum J.,et al.Neuroproteomics:expression profiling of the brain's proteomes in health and disease[J].Neurochemical Research,2004,29:1317.
  • 4[4]Hague S.M.,Klaffke S.,Bandmann O..Neurodegenerative disorders:Parkinson's disease and Huntington's disease[J].J Neurol Neurosurg Psychiatry,2005,76:1058.
  • 5[5]Iuliis A.D.,Grigoletto J.,Recchia A.,et al.A proteomic approach in the study of an animal model of Parkinson's disease[J].Clinica Chimica Acta,2005,357:202.
  • 6[6]Costa C.A..Recent advances on alpha-synuclein cell biology:functions and dysfunctions[J].Curr Mol Med,2003; 3:17.
  • 7[7]Abeliovich A.,Schmitz Y.,Farinas I.,et al.Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system[J].Neuron,2000,25:239.
  • 8[8]Kirik D.,Annett L.E.,Burger C.,et al.Nigrostriatal alpha-synucleinopathy induced by viral vector-mediated overexpression of human alpha-synuclein:a new primate model of Parkinson's disease[J].Proc Natl Acad Sci USA,2003,100:2884.
  • 9[9]Xu J.,Kao S.Y.,Lee F.J.S.,et al.Dopamine-dependent neurotoxicity of alpha-synuclein:a mechanism for selective neurodegeneration in Parkinson disease[J].Nature Medicine,2002,8:600.
  • 10[10]Mandel S.,Grunblatt E.,Riederer P.,et al.Neuroprotective strategies in Parkinson's disease:an update on progress[J].CNS Drugs,2003,17:729.

同被引文献32

  • 1马龙.熄风定颤丸治疗帕金森病40例[J].中医研究,2008,21(3):39-42. 被引量:10
  • 2马云枝,李社芳,沈晓明,贾奎.中西医结合治疗帕金森病30例疗效观察[J].新中医,2005,37(10):55-56. 被引量:18
  • 3程传浩,马云枝,马龙,王俊锋.熄风定颤丸对帕金森病患者美多巴用量影响的研究[J].山西中医,2007,23(1):35-36. 被引量:13
  • 4Benabid AL,Chabardes S,Mitrofanis J,et al.Deep brainstimulation of the subthalamic nucleus for the treatment ofParkinson's disease[J].Lancet Neurol,2009,8(1):67-81.
  • 5Davidsson P,Sjogren M.The use of proteomics in bio-marker discovery in neurodegenerative diseases[J].DisMarkers,2005,21(2):81-92.
  • 6Kim SI,Voshol H,van Oostrum J,et al.Neuroproteomics:expression profiling of the brain's proteomes in health anddisease[J].Neurochem Res,2004,29(6):1317-1331.
  • 7Benabid AL.Deep brain stimulation for Parkinson's disease[J].Curr Opin Neurobiol,2003,13(6):696-706.
  • 8Mclntyre CC,Savasta M,Walter BL,et al.How does deepbrain stimulation work?Present understanding and futurequestions[J].J Clin Neurophysiol,2004,21(1):40-50.
  • 9Ogura M,Nakao N,Nakai E,et al.Chronic electrical stimu-lation of the globus pallidus for treatment of Parkinson'sdisease[J].International Congress Series,2002,1232:895-899.
  • 10Trost M,Su S,Su P,et al.Network modulation by thesubthalamic nucleus in the treatment of parkinson's disease[J].Neuroimage,2006,31(1):301-307.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部